Rebecca Derwin

Director, Early Commercial Strategy and Insights at REGENXBIO Inc. - Rockville, Maryland, US

Rebecca Derwin's Colleagues at REGENXBIO Inc.
Kenneth Robinson

Senior Director, Rare Disease MSLs

Contact Kenneth Robinson

Michael Winkler

Director, Downstream PD and Process Validation

Contact Michael Winkler

Tristan Marshall

Sr. Director - Pharmaceutical Development

Contact Tristan Marshall

Mary DiMarco

Assoc. Director, Regulatory Operations

Contact Mary DiMarco

James Folmer

Director, Program Management

Contact James Folmer

Justin Horvath

Director Of External Mfg/Mfg Sciences

Contact Justin Horvath

Sarang Rastogi

Director , Global Clinical Development Lead

Contact Sarang Rastogi

View All Rebecca Derwin's Colleagues
Rebecca Derwin's Contact Details
Email (Verified)
***@regenxbio.com
Get Rebecca Derwin's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Rebecca Derwin's Mobile Number
HQ
(240) 552-8181
Location
Company
REGENXBIO Inc.
Rebecca Derwin's Company Details
REGENXBIO Inc. logo, REGENXBIO Inc. contact details

REGENXBIO Inc.

Rockville, Maryland, US • 500 - 999 Employees
BioTech/Drugs

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.

Gene Editing Genetic Testing Molecular Biology Biotechnology
Details about REGENXBIO Inc.
Frequently Asked Questions about Rebecca Derwin
Rebecca Derwin currently works for REGENXBIO Inc..
Rebecca Derwin's role at REGENXBIO Inc. is Director, Early Commercial Strategy and Insights.
Rebecca Derwin's email address is ***@regenxbio.com. To view Rebecca Derwin's full email address, please signup to ConnectPlex.
Rebecca Derwin works in the BioTech/Drugs industry.
Rebecca Derwin's colleagues at REGENXBIO Inc. are Kenneth Robinson, Michael Winkler, Tristan Marshall, Mary DiMarco, James Folmer, Justin Horvath, Sarang Rastogi and others.
Rebecca Derwin's phone number is (240) 552-8181
See more information about Rebecca Derwin